Breaking News, Collaborations & Alliances

NOVA Expands JINKO Platform Pact with Janssen

Implements its JINKO clinical trial simulation platform for the development of lung cancer models.

Author Image

By: Charlie Sternberg

Associate Editor

Novadiscovery (NOVA), a health tech company using in silico clinical trials to predict drug efficacy and optimize clinical trial development, has expanded its collaboration with Janssen, initially entered in 2020.   NOVA is now applying its collaborative clinical trial simulation platform, JINKO, to expand the existing lung cancer model to support Janssen market access and global medical affairs strategies.   This agreement follows an agreement which saw NOVA use publicly-available knowledge...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters